000 | 01919 a2200529 4500 | ||
---|---|---|---|
005 | 20250517105327.0 | ||
264 | 0 | _c20170707 | |
008 | 201707s 0 0 eng d | ||
022 | _a1743-6109 | ||
024 | 7 |
_a10.1016/j.jsxm.2016.05.016 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFarmer, Melissa | |
245 | 0 | 0 |
_aFuture Targets for Female Sexual Dysfunction. _h[electronic resource] |
260 |
_bThe journal of sexual medicine _c08 2016 |
||
300 |
_a1147-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAlprostadil _xtherapeutic use |
650 | 0 | 4 |
_aAnxiety _xetiology |
650 | 0 | 4 |
_aAphrodisiacs _xtherapeutic use |
650 | 0 | 4 |
_aApomorphine _xtherapeutic use |
650 | 0 | 4 | _aConsensus |
650 | 0 | 4 |
_aDehydroepiandrosterone _xtherapeutic use |
650 | 0 | 4 |
_aDopamine _xphysiology |
650 | 0 | 4 |
_aDopamine Agonists _xtherapeutic use |
650 | 0 | 4 |
_aDopamine Uptake Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aEvidence-Based Medicine |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aForecasting |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMelanocortins _xagonists |
650 | 0 | 4 |
_aNeurotransmitter Agents _xtherapeutic use |
650 | 0 | 4 |
_aNitric Oxide Donors _xtherapeutic use |
650 | 0 | 4 |
_aPelvic Pain _xtherapy |
650 | 0 | 4 | _aPharmacogenomic Testing |
650 | 0 | 4 |
_aPhosphodiesterase 5 Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aPsychotherapy _xmethods |
650 | 0 | 4 |
_aSerotonin _xphysiology |
650 | 0 | 4 |
_aSexual Behavior _xpsychology |
650 | 0 | 4 |
_aSexual Dysfunction, Physiological _xtherapy |
650 | 0 | 4 |
_aSexual Dysfunctions, Psychological _xtherapy |
650 | 0 | 4 |
_aTestosterone _xtherapeutic use |
650 | 0 | 4 |
_aTranscranial Magnetic Stimulation _xmethods |
700 | 1 | _aYoon, Hana | |
700 | 1 | _aGoldstein, Irwin | |
773 | 0 |
_tThe journal of sexual medicine _gvol. 13 _gno. 8 _gp. 1147-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jsxm.2016.05.016 _zAvailable from publisher's website |
999 |
_c26244816 _d26244816 |